Skip to main content
. Author manuscript; available in PMC: 2014 Feb 23.
Published in final edited form as: J Pharm Biomed Anal. 2012 Oct 22;74:10.1016/j.jpba.2012.10.016. doi: 10.1016/j.jpba.2012.10.016

Table 1.

MS conditions for the CYP metabolites and internal standards

Enzyme Metabolites Precursor ion mass (m/z) Product ion mass (m/z) Ionisation Mode Cone voltage (V) Collision energy (eV) Retention time (min.)
CYP1A2 Acetaminophen 152.03 110.03 ESI + 25 15 4.26
CYP2C9 4′-Hydroxy diclofenac 311.82 229.97 ESI + 25 32 5.24
CYP2C19 4-Hydroxy mephenytoin 234.91 132.77 ESI + 30 20 4.64
CYP2D6 Dextrorphan 257.98 156.96 ESI + 30 30 4.29
CYP3A4 1′-Hydroxy midazolam 341.91 323.85 ESI + 20 25 5.09
Enzyme Internal Standards Precursor ion mass (m/z) Product ion mass (m/z) Ionisation mode Cone voltage (V) Collision energy (eV) Retention time (min.)
CYP1A2 Acetaminophen-D4 155.71 113.86 ESI + 25 15 4.26
CYP2C9 4′-Hydroxy Diclofenac-D4 315.82 234.00 ESI + 25 32 5.24
CYP2C19 Mephenytoin-d3 237.88 150.03 ESI + 30 20 4.64
CYP2D6 Dextrorphan-d3 261.00 244.00 ESI + 30 30 4.29
CYP3A4 Midazolam-d5 330.76 295.77 ESI + 20 25 4.79